Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Equifax Sees Q2 Adj. EPS $1.65-$1.75 vs $1.87 Est., Revenue $1.41B-$1.43B vs $1.44B Est.; Sees FY24 Adj. EPS $7.20-$7.50 vs $7.64 Est., Revenue $5.67B-$5.77B vs $5.78B Est.

Author: Benzinga Newsdesk | April 17, 2024 04:14pm

Posted In: EFX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist